Cubist Systematic Strategies’s Atea Pharmaceuticals AVIR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-34,045
| Closed | -$113K | – | 1497 |
|
|
2024
Q2 | $113K | Sell |
34,045
-60,080
| -64% | -$199K | ﹤0.01% | 1159 |
|
|
2024
Q1 | $380K | Sell |
94,125
-84,228
| -47% | -$340K | ﹤0.01% | 1467 |
|
|
2023
Q4 | $544K | Buy |
178,353
+39,280
| +28% | +$120K | ﹤0.01% | 1339 |
|
|
2023
Q3 | $417K | Buy |
139,073
+98,081
| +239% | +$294K | ﹤0.01% | 1323 |
|
|
2023
Q2 | $153K | Sell |
40,992
-34,570
| -46% | -$129K | ﹤0.01% | 1734 |
|
|
2023
Q1 | $253K | Buy |
75,562
+34,438
| +84% | +$115K | ﹤0.01% | 2105 |
|
|
2022
Q4 | $198K | Buy |
+41,124
| New | +$198K | ﹤0.01% | 2647 |
|
|
2022
Q3 | – | Sell |
-26,656
| Closed | -$189K | – | 3612 |
|
|
2022
Q2 | $189K | Sell |
26,656
-97,884
| -79% | -$694K | ﹤0.01% | 3201 |
|
|
2022
Q1 | $899K | Sell |
124,540
-301,280
| -71% | -$2.17M | 0.01% | 2110 |
|
|
2021
Q4 | $3.81M | Buy |
425,820
+417,795
| +5,206% | +$3.74M | 0.04% | 843 |
|
|
2021
Q3 | $281K | Sell |
8,025
-37,432
| -82% | -$1.31M | ﹤0.01% | 2395 |
|
|
2021
Q2 | $976K | Buy |
45,457
+40,557
| +828% | +$871K | 0.01% | 1590 |
|
|
2021
Q1 | $303K | Buy |
+4,900
| New | +$303K | ﹤0.01% | 2245 |
|